Iq Eq Fund Management (Ireland) LTD Gt Biopharma, Inc. Transaction History

Iq Eq Fund Management (Ireland) LTD

  • $934 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021
SELL
$6.68 - $15.26 $234,554 - $535,824
-35,113 Closed
0 $0
Q2 2021

Jul 19, 2021
BUY
$7.19 - $18.96 $63,214 - $166,696
8,792 Added 33.4%
35,113 $544,000
Q1 2021

May 11, 2021
BUY
$4.4 - $8.84 $115,812 - $232,677
26,321 New
26,321 $180,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $96.4M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email